OCIL Specialty Ltd (OCL) is a wholly-owned subsidiary of Everen Specialty Ltd. As of June 1, 2026, OCIL Specialty Ltd (OCL) has transitioned to a legacy business that continues to support our shareholders with claims payments. 

The company is not authorized to, and does not transact business in the United States and Canada.

If you wish to contact a member of our team please click below: